BR112013029203A2 - método para a preparação de um ou mais oligossacarídeos de leite humano, e, uso de oligossacarídeos de leite humano - Google Patents

método para a preparação de um ou mais oligossacarídeos de leite humano, e, uso de oligossacarídeos de leite humano

Info

Publication number
BR112013029203A2
BR112013029203A2 BR112013029203A BR112013029203A BR112013029203A2 BR 112013029203 A2 BR112013029203 A2 BR 112013029203A2 BR 112013029203 A BR112013029203 A BR 112013029203A BR 112013029203 A BR112013029203 A BR 112013029203A BR 112013029203 A2 BR112013029203 A2 BR 112013029203A2
Authority
BR
Brazil
Prior art keywords
human milk
milk oligosaccharides
preparing
oligosaccharides
human
Prior art date
Application number
BR112013029203A
Other languages
English (en)
Inventor
Andreas Schroven
Elise Champion
Gyula Dekany
Markus Hederos
Original Assignee
Glycom As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2012/051314 external-priority patent/WO2012127410A1/en
Application filed by Glycom As filed Critical Glycom As
Publication of BR112013029203A2 publication Critical patent/BR112013029203A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/14Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/12Disaccharides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
BR112013029203A 2011-05-13 2012-05-14 método para a preparação de um ou mais oligossacarídeos de leite humano, e, uso de oligossacarídeos de leite humano BR112013029203A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11166137 2011-05-13
PCT/IB2012/051314 WO2012127410A1 (en) 2011-03-18 2012-03-19 Synthesis of new fucose-containing carbohydrate derivatives
PCT/IB2012/052401 WO2012156898A1 (en) 2011-05-13 2012-05-14 DIVERSIFICATION OF HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF

Publications (1)

Publication Number Publication Date
BR112013029203A2 true BR112013029203A2 (pt) 2016-08-09

Family

ID=47176364

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013029203A BR112013029203A2 (pt) 2011-05-13 2012-05-14 método para a preparação de um ou mais oligossacarídeos de leite humano, e, uso de oligossacarídeos de leite humano

Country Status (14)

Country Link
US (2) US9382564B2 (pt)
EP (2) EP2707380B1 (pt)
JP (1) JP6106160B2 (pt)
KR (1) KR20140036226A (pt)
CN (1) CN103562214B9 (pt)
BR (1) BR112013029203A2 (pt)
CA (1) CA2835989A1 (pt)
DK (1) DK2707380T3 (pt)
ES (1) ES2820429T3 (pt)
IL (1) IL229047A0 (pt)
MX (1) MX349153B (pt)
PL (1) PL2707380T3 (pt)
RU (1) RU2013155453A (pt)
WO (1) WO2012156898A1 (pt)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140001198A (ko) 2010-07-16 2014-01-06 글리콤 에이/에스 신규 시알로올리고당 유도체들의 합성
WO2013091660A1 (en) * 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
WO2014090261A1 (en) * 2012-12-14 2014-06-19 Glycom A/S Mixture of fucosylate lactoses
GB201306689D0 (en) 2013-04-12 2013-05-29 Glycom As Synthesis of sialylated/fucosylated human milk oligosaccharides
CN105246911B (zh) * 2013-04-12 2019-10-01 丹麦科技大学 用于产生唾液酸化聚糖之具有转唾液酸酶活性的突变体唾液酸酶
ES2891731T3 (es) 2013-05-22 2022-01-31 Glycom As Mezcla sintética de oligosacáridos para el tratamiento de la microbiota de un mamífero
EP3041947A4 (en) 2013-09-06 2017-07-26 Glycom A/S Fermentative production of oligosaccharides
EP2857410A1 (en) * 2013-10-04 2015-04-08 Jennewein Biotechnologie GmbH Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
PL3209673T5 (pl) * 2014-10-24 2023-10-23 Glycom A/S Mieszaniny hmo
WO2016063261A1 (en) * 2014-10-24 2016-04-28 Glycom A/S Mutated fucosidase
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
EP3212198B1 (en) 2014-10-29 2020-12-23 Glycom A/S Synthetic composition and method for promoting mucosal healing
JP7182872B2 (ja) 2014-10-29 2022-12-05 グリコム・アクティーゼルスカブ 過敏性腸症候群の治療のための合成組成物および方法
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
CN107106584A (zh) 2014-12-08 2017-08-29 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
CN115300517A (zh) * 2015-03-31 2022-11-08 格礼卡姆股份公司 包含3’-o-唾液乳糖的人乳寡糖的混合物
ES2870973T3 (es) * 2015-06-09 2021-10-28 Glycom As Mezclas ternarias de 6'-SL, LNnT y LST c
DK3307882T3 (da) * 2015-06-09 2020-05-18 Glycom As Mutated photobacterium transsialidases
ES2772685T3 (es) 2015-08-04 2020-07-08 Nestle Sa Composiciones nutricionales con 2FL y LNNT para inducir una microbiota intestinal similar a la de los bebés lactantes
US10751354B2 (en) 2015-09-14 2020-08-25 Glycom A/S Synthetic composition for microbiota modulation
EP3368046B1 (en) 2015-10-28 2022-07-27 Glycom A/S Synthetic composition and method for modulating brain function and behaviour
ES2950489T3 (es) 2015-10-28 2023-10-10 Glycom As Composición sintética y método para modular los trastornos de la emoción y del ánimo
CN108348536B (zh) 2015-11-17 2021-09-24 格礼卡姆股份公司 治疗抗生素相关性并发症的合成组合物
EP3389668A4 (en) 2015-12-15 2019-08-21 Glycom A/S MIX OF HMO
EP3419630A4 (en) 2016-02-24 2019-11-06 Glycom A/S SYNTHETIC COMPOSITION OF MICROBIOTIC MODULATION
WO2017190755A1 (en) 2016-05-05 2017-11-09 Glycom A/S Composition comprising hmos for use in the treatment of mast cell mediated visceral hypersensitivity and/or pain
PL3452050T3 (pl) 2016-05-05 2023-06-12 Glycom A/S Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej
WO2017198276A1 (en) 2016-05-19 2017-11-23 Glycom A/S Synthetic composition
EP3474861A4 (en) 2016-06-24 2020-04-15 Glycom A/S COMPOUNDS COMPRISING HMOS FOR THE PREVENTION AND / OR TREATMENT OF VIRAL AND / OR BACTERIAL INFECTIONS.
EP3490567A4 (en) 2016-07-28 2020-03-18 Fonterra Co-Operative Group Limited DAIRY PRODUCT AND DAIRY PROCESS
US11278558B2 (en) 2017-03-01 2022-03-22 Glycom A/S Synthetic composition for microbiota modulation
EP3634429A4 (en) 2017-05-09 2020-11-04 Glycom A/S SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
WO2018215960A1 (en) 2017-05-24 2018-11-29 Glycom A/S Synthetic composition comprising one or more human milk oligosaccharides (hmos)
WO2018215961A1 (en) 2017-05-24 2018-11-29 Glycom A/S Synthetic composition comprising oligosaccharides and its use in medical treatment.
EP3645545A4 (en) 2017-06-30 2021-05-05 Glycom A/S PURIFICATION OF OLIGOSACCHARIDES
EP3672600A4 (en) 2017-08-21 2021-05-19 Glycom A/S SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
EP3450443A1 (en) * 2017-08-29 2019-03-06 Jennewein Biotechnologie GmbH Process for purifying sialylated oligosaccharides
CA3081496A1 (en) 2017-11-02 2019-05-09 Glycom A/S Mixture of hmos for reducing or preventing fatigue
BR112020010863A2 (pt) 2017-11-30 2020-11-10 Glycom A/S mistura de hmos para tratamento da sensibilidade ao trigo
CN111556755A (zh) 2017-12-05 2020-08-18 格礼卡姆股份公司 用于治疗偏头痛的人乳寡糖
US11566219B2 (en) * 2017-12-08 2023-01-31 Morinaga Milk Industry Co., Ltd. Bifidobacterium bacteria and composition including novel bifidobacterium bacteria
WO2019123316A1 (en) 2017-12-22 2019-06-27 Glycom A/S Composition comprising hmos for preventing or reducing nociception
EP3801558A4 (en) 2018-05-31 2022-03-09 Glycom A/S HMOS BLEND FOR THE TREATMENT OF AUTOIMMUNE DISEASES
CN113194960A (zh) 2018-12-19 2021-07-30 格礼卡姆股份公司 用于治疗使用低fodmap饮食的人的组合物和方法
CN110016066B (zh) * 2019-04-02 2021-11-02 江西师范大学 一种i型n-聚糖天线的合成方法
CN114350640B (zh) * 2019-12-13 2023-09-08 中国科学院天津工业生物技术研究所 一株表达几丁质酶重组菌的构建及高酶活突变体的筛选
WO2022089707A1 (en) 2020-10-30 2022-05-05 Mille International Aps A method of producing a human milk oligosaccharide (hmo)
CN112795583A (zh) * 2020-11-16 2021-05-14 上海大学 重组唾液酸外切酶的制备方法、表达基因、重组表达载体及构建方法
WO2022223430A1 (en) 2021-04-19 2022-10-27 Dsm Ip Assets B.V. A composition of enzymes and human milk oligosaccharides
CN113960232B (zh) * 2021-10-28 2024-02-20 苏州大学 一种基于唾液特异性岩藻糖基化结构糖谱及其检测方法和应用
DK202200588A1 (en) 2022-06-20 2024-02-23 Dsm Ip Assets Bv Mixture of fucosylated HMOs
WO2024042235A1 (en) 2022-08-25 2024-02-29 Dsm Ip Assets B.V. Hybrid method for producing complex hmos
WO2024110667A1 (en) 2022-11-25 2024-05-30 Dsm Ip Assets B.V. Two-strain system for producing oligosaccharides
DK202201151A1 (en) 2022-12-14 2024-07-02 Dsm Ip Assets Bv Mutated lacto-n-biosidase

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018787A1 (en) * 1992-03-25 1993-09-30 New York University Trans-sialidase and methods of use and making thereof
JPH0686684A (ja) 1992-05-26 1994-03-29 Monsanto Co シアロ抱合体の合成
US5409817A (en) * 1993-05-04 1995-04-25 Cytel, Inc. Use of trans-sialidase and sialyltransferase for synthesis of sialylα2→3βgalactosides
EP0820520B1 (en) 1995-04-11 2002-08-14 Neose Technologies, Inc. Improved enzymatic synthesis of oligosaccharides
US6323008B1 (en) 1997-08-14 2001-11-27 Neose Technologies, Inc. Methods for producing sialyloligosaccharides in a dairy source
US20050032742A1 (en) 2001-08-17 2005-02-10 Defrees Shawn Chemo-enzymatic synthesis of sialylated oligosaccharides
WO2005055944A2 (en) * 2003-12-05 2005-06-23 Cincinnati Children's Hospital Medical Center Oligosaccharide compositions and use thereof in the treatment of infection
US8591981B2 (en) * 2005-02-21 2013-11-26 Nestec S.A. Oligosaccharide mixture
JP4937288B2 (ja) 2009-03-02 2012-05-23 シャープ株式会社 画像読取装置及び画像形成装置
WO2011100980A1 (en) 2010-02-19 2011-08-25 Glycom A/S A method for preparation of the tetrasaccharide lacto-n-neotetraose (lnnt) containing n-acetyllactosamine
KR20140001198A (ko) 2010-07-16 2014-01-06 글리콤 에이/에스 신규 시알로올리고당 유도체들의 합성
RU2013146524A (ru) 2011-03-18 2015-04-27 Глюком А/С Синтез новых фукозо-содержащих производных углеводородов

Also Published As

Publication number Publication date
US20140212930A1 (en) 2014-07-31
US9963729B2 (en) 2018-05-08
JP2014513986A (ja) 2014-06-19
US20160289721A1 (en) 2016-10-06
EP3744725A1 (en) 2020-12-02
CA2835989A1 (en) 2012-11-22
ES2820429T3 (es) 2021-04-21
MX349153B (es) 2017-07-14
CN103562214B9 (zh) 2016-12-14
DK2707380T3 (da) 2020-10-12
PL2707380T3 (pl) 2021-01-11
KR20140036226A (ko) 2014-03-25
EP2707380A4 (en) 2014-10-08
WO2012156898A1 (en) 2012-11-22
RU2013155453A (ru) 2015-06-20
US9382564B2 (en) 2016-07-05
JP6106160B2 (ja) 2017-03-29
EP2707380A1 (en) 2014-03-19
CN103562214A (zh) 2014-02-05
EP2707380B1 (en) 2020-07-08
CN103562214B (zh) 2016-10-19
IL229047A0 (en) 2013-12-31
MX2013013027A (es) 2013-12-02

Similar Documents

Publication Publication Date Title
BR112013029203A2 (pt) método para a preparação de um ou mais oligossacarídeos de leite humano, e, uso de oligossacarídeos de leite humano
BR112013029208A2 (pt) método para preparar um ou mais oligossarídeos de leite humano ou derivados ou precursores dos mesmos, uso de oligossacarídeos, e, composto
ZA201503753B (en) Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof
BR112014029875A2 (pt) cápsula, dispositivo de preparação, método para preparar uma bebida, uso de uma cápsula e embalagem.
BR112013019637A2 (pt) sistemas, aparelho e métodos para implantação de implantes
BR112015002868A2 (pt) dispositivos, sistemas e métodos para se engajar tecido
BR112013033758A2 (pt) recipiente, uso, dialisador ou unidade de preparação além de método para fabricação de um concentrado
BR112015003042A2 (pt) sistema médico, e, método médico para um dispositivo hub de um sistema médico de rede de área corporal (mban)
BR112014010206A2 (pt) composto, composição farmacêutica, uso de composto, e, método para a profilaxia ou tratamento de um estado ou condição de doença
BR112014001346A2 (pt) composto nanotransportador, método, composto farmacêutico e uso de um composto
BR112013033811A2 (pt) composição, método de preparação da composição, e, composto
BR112014010179A2 (pt) composto, composição farmacêutica, uso de um composto, e, método para a profilaxia ou tratamento de um estado ou condição
BR112015015758A2 (pt) dispersão sólida, formulação sólida, método de preparo de uma dispersão sólida, preparação farmacêutica e uso de uma dispersão sólida
BR112015002755A2 (pt) derivado de ácido hialurônico, método de preparação de derivado de ácido hialurônico, método de modificação de derivado de ácido hialurônico e uso de derivados
BR112012025375A2 (pt) compósito absorvente, artigo de cuidade pessoal absorvente e método para preparação de um artigo de cuidado pessoal absorvente
BR112014024676A2 (pt) Adsorvedor de iodeto de metila, sua utilização e método para a adsorção de iodeto de metila.
ES2603028T8 (es) Procedimiento para la preparación de (Z)-alfa-fluoro-beta-amino-acrilaldehídos sustituidos
BR112014009574A2 (pt) aparelho para monitorar um ou mais parâmetros oculares
CO7000778A2 (es) Derivados de pirazolopiridina, su procedimiento de preparación y su uso terapéutico
IL225972A0 (en) Salts of cocuamine b, a method for their preparation and use
BR112013019631A2 (pt) sistemas cirúrgicos e métodos para estes.
BR112014012143A2 (pt) soluções de colina estabilizadas e métodos para preparação das mesmas
CO6910193A2 (es) Derivados de anilina, su preparación y su aplicación terapéutica
BR112013017320A2 (pt) dispositivo de amostragem de sangue, e, método para produzir um dispositivo de amostragem de sangue
BR112015002464A2 (pt) processo para a preparação de carbamat-benzoxazinonas, carbamat-benzoxazinonas e utilização das carbamat-benzoxazinonas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]